A detailed history of Krilogy Financial LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Krilogy Financial LLC holds 30,765 shares of EXAS stock, worth $2.02 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
30,765
Previous 26,914 14.31%
Holding current value
$2.02 Million
Previous $1.86 Million 30.09%
% of portfolio
0.1%
Previous 0.15%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$41.33 - $74.26 $159,161 - $285,975
3,851 Added 14.31%
30,765 $1.3 Million
Q1 2024

Apr 24, 2024

BUY
$56.27 - $73.77 $413,021 - $541,471
7,340 Added 37.5%
26,914 $1.86 Million
Q4 2023

Jan 26, 2024

SELL
$59.06 - $75.72 $165,368 - $212,016
-2,800 Reduced 12.51%
19,574 $1.45 Million
Q3 2023

Nov 01, 2023

BUY
$65.94 - $99.04 $673,577 - $1.01 Million
10,215 Added 84.01%
22,374 $1.53 Million
Q2 2023

Jul 19, 2023

SELL
$62.68 - $95.05 $373,322 - $566,117
-5,956 Reduced 32.88%
12,159 $1.14 Million
Q1 2023

May 03, 2023

BUY
$47.19 - $70.77 $268,794 - $403,105
5,696 Added 45.87%
18,115 $1.23 Million
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $150,293 - $263,198
-4,952 Reduced 28.51%
12,419 $614,000
Q3 2022

Oct 06, 2022

SELL
$31.97 - $49.37 $31 - $49
-1 Reduced 0.01%
17,371 $564,000
Q2 2022

Jul 14, 2022

BUY
$35.61 - $76.23 $467,879 - $1 Million
13,139 Added 310.39%
17,372 $684,000
Q1 2022

Apr 28, 2022

SELL
$57.56 - $82.54 $623,087 - $893,495
-10,825 Reduced 71.89%
4,233 $296,000
Q4 2021

Jan 27, 2022

BUY
$72.5 - $100.68 $353,800 - $491,318
4,880 Added 47.95%
15,058 $1.17 Million
Q3 2021

Oct 25, 2021

BUY
$90.24 - $124.05 $63,799 - $87,703
707 Added 7.46%
10,178 $971,000
Q2 2021

Jul 20, 2021

BUY
$93.66 - $139.27 $21,354 - $31,753
228 Added 2.47%
9,471 $1.18 Million
Q1 2021

Apr 21, 2021

BUY
$116.57 - $155.01 $59,567 - $79,210
511 Added 5.85%
9,243 $1.22 Million
Q4 2020

Feb 11, 2021

SELL
$99.61 - $142.12 $11,753 - $16,770
-118 Reduced 1.33%
8,732 $1.16 Million
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $7,437 - $10,405
-102 Reduced 1.14%
8,850 $902,000
Q2 2020

Aug 06, 2020

SELL
$55.75 - $92.75 $651,773 - $1.08 Million
-11,691 Reduced 56.63%
8,952 $778,000
Q1 2020

May 13, 2020

BUY
$37.9 - $104.44 $782,369 - $2.16 Million
20,643 New
20,643 $1.2 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $11,208 - $16,532
-200 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $9,658 - $16,119
200 New
200 $16,000
Q2 2018

Aug 15, 2018

SELL
$37.84 - $69.96 $64,328 - $118,931
-1,700 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $15,928 - $23,012
400 Added 30.77%
1,700 $69,000
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $4,649 - $6,051
100 Added 8.33%
1,300 $68,000
Q3 2017

Nov 15, 2017

SELL
$37.05 - $47.12 $100,034 - $127,224
-2,700 Reduced 69.23%
1,200 $57,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,900
3,900 $138,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.6B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.